Enfermedades Sistémicas de Base Autoinmune

Loricera, J; Molina-Collada, J; Nieto, JC; Sánchez-Lucas, M; Silva-Díaz, MT; Moya, P; Labrador, E; Ferraz-Amaro, I; Blanco, R.

Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients

DRUGS & AGING. 2026; : [doi:10.1007/s40266-026-01281-1]

Monjo-Henry, I; Fernández-Fernández, E; Miranda-Carus, ME; Nieto-Carvalhal, B; Ortíz, GT; Molina-Collada, J; De Miguel, E.

Dynamic vascular changes on long-term ultrasound monitoring predict relapse in large-vessel giant cell arteritis

ARTHRITIS RESEARCH & THERAPY. 2026; 28(1): [doi:10.1186/s13075-026-03759-0]

Rebollo-Giménez, AI; Rosina, S; Ridella, F; Orsi, SM; Aldera, E; Burrone, M; Natoli, V; Consolaro, A; Bovis, F; Naredo, E; Ravelli, A.

Discordance between non-zero physician's global scores and absence of active joints in juvenile idiopathic arthritis: multicenter vs. single-center cohorts

Frontiers In Pediatrics. 2026; 14: [doi:10.3389/fped.2026.1702667]

Macmahon, JM; Ravelli, A; Rebollo-Giménez, AI; Natoli, V; Campone, C; Bovis, F; Nozawa, T; Goh, YI; Consolaro, A; Feldman, BM; Rosina, S.

Toward a Treat-to-Target Strategy in Juvenile Dermatomyositis: What Are the Suitable Targets and Optimal Timing of Their Achievement?

ARTHRITIS & RHEUMATOLOGY. 2026; : [doi:10.1002/art.43431]

Vidal-Montal, P; Fabregat, A; Altabás-González, I; Pego-Reigosa, JM; Hernández-Martínez, A; Rua-Figueroa, I; Salman-Monte, T; Moriano, C; Segura, BT; Vela, P; Pareja-Martínez, A; García-Cirera, S; García-Villanueva, MJ; Garrote-Corral, S; Heredia, S; Riancho-Zarrabeitia, L; Manrique-Arija, S; Bernárdez, J; Magallares, B; Torrente-Segarra, V; Frade-Sosa, B; Gómez-Puerta, JA; Martinez-Barrio, J; Narvaez, J.

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry

LUPUS SCIENCE & MEDICINE. 2026; 13(1): [doi:10.1136/lupus-2025-001825]

Rua-Figueroa, I; Martínez-Barrio, J; Plaza, Z; Jiménez, N; Galindo-Izquierdo, M; Uriarte, E; Fernandez-Nebro, A; Alen, JC; Rosas, J; Narváez, J; Aurrecoechea, E; Freire, M; Tomero, E; Sanguesa, C; Iniguez, C; Perez, A; Garrote, S; Lozano-Rivas, N; Ibarguengoitia, O; Salgado, E; Erausquin, C; Monte, TCS; Menor, R; Altabás-González, I; Gil, JF; Nolla, JM; Pego-Reigosa, JM.

Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data

Bmc Rheumatology. 2026; 10(1): [doi:10.1186/s41927-025-00612-w]

Molina-Collada, J; Ponte, C; Schäfer, VS; de Miguel, E.

Imaging-guided stratification in giant cell arteritis: prognostic and therapeutic implications

Therapeutic Advances in Musculoskeletal Disease. 2026; 18: [doi:10.1177/1759720X251414122]

Retuerto-Guerrero, M; Morales, CM; Pareja-Martínez, A; Molina-Esteban, N; Puig-Buendia, J; Llorente, CP; Cofiño, ALC; Martínez-Barrio, J; Vidal-Montal, P; Cudos, ES; Cabrera, LM; Arribas, GG; Alén, JC; de Aberasturi, JRDJ; Madrigal, JMB; Corral, JB; Oliva, AC; Casasempere, PV; Gonzalez, MC; Manteca, MCF; Capusan, TM; Calvo, CO; Rodríguez, DR; Herrero, AS; Ortega-Valín, L; Alvarez, ED.

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study

RHEUMATOLOGY. 2025; 65(2): [doi:10.1093/rheumatology/keaf662]

Altabás-González, I; Rua-Figueroa, I; Roberts, K; Mamani, IL; Mouriño, C; Martinez-Barrio, J; Izquierdo, MG; Calvo-Alén, J; Erausquin, C; Serrano-Benavente, B; Uriarte, E; Tomero, E; Freire-González, M; Blanco, R; Salgado, E; Gomez-Sabater, S; Fernandez-Nebro, A; Sangüesa, C; Narvaez, J; Vázquez, NM; Menor-Almagro, R; de Salazar, JCRG; Aurrecoechea, E; Ibarguengoitia-Barrena, O; Montilla, C; Bonilla, G; Segarra, VT; Juan-Mas, A; García-Villanueva, MJ; Morales, CM; Horcada, L; Lozano-Rivas, N; Iñiguez, C; Arevalo, M; Paredes, B; Exposito, L; Toyos, FJ; Flores-Fernandez, E; Medina, JN; Gil, JJF; Bohorquez, C; Pego-Reigosa, JM.

Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality

LUPUS SCIENCE & MEDICINE. 2025; 12(2): [doi:10.1136/lupus-2025-001766]

Martín-Gutiérrez A; Loricera J; Prieto-Peña D; Aldasoro V; Maiz O; de Miguel E; Galíndez-Agirregoikoa E; Ferraz-Amaro I; Castañeda S; Blanco R.

Tocilizumab monotherapy versus combined in aortitis associated with giant cell arteritis: Factors associated with imaging remission in a multicenter open-label study of 196 patients.

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 75: 152869-152869 [doi:10.1016/j.semarthrit.2025.152869]

Quesada-Masachs, E; de Inocencio, J; González, JCN; Sáez, IM; Loza, SM; san Ildefonso, MM; Hernández, JC; Penadés, IC; Zabala, RG; Corbeto, ML; Anton, J.

Cervical spine arthritis as initial manifestation in Juvenile Idiopathic Arthritis: a multicenter retrospective study

Pediatric Rheumatology. 2025; 23(1): [doi:10.1186/s12969-025-01161-9]

Molina-Collada, J; Otero-Varela, L; Vela, P; Manrique, S; Erausquin, C; Campos, C; Manero, J; Calvo, J; Expósito, L; González, JG; Montesinos, MDR; Rabadán, E; Varela, AM; Vilamajo, IR; Burlato, MC; Plasencia, C; Sánchez-Alonso, F; Castrejón, I.

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry

RHEUMATOLOGY. 2025; 65(1): [doi:10.1093/rheumatology/keaf556]

Trives-Folguera, L; Anzola, AM; Monteagudo-Saez, I; Nieto-González, JC.

Real life treatment in juvenile idiopathic arthritis: Is remission long lasting?

Reumatologia Clinica. 2025; 21(8): [doi:10.1016/j.reuma.2025.501949]

Ibarguengoitia-Barrena, O; Riancho-Zarrabeitia, L; Plaza, Z; Rúa-Figueroa, I; Roberts, K; Martinez-Taboada, V; Menor-Almagro, R; Serrano-Benavente, B; Rubio-Munoz, P; Galindo-Izquierdo, M; Fernandez-Nebro, A; Ruiz-Lucea, ME; Calvo-Alen, J; Tomero-Muriel, EG; Uriarte-Isacelaya, E; Pecondon-Espano, A; Freire, M; Garcia-Fernandez, J; Exposito, L; Ibanez-Barcelo, M; Aurrecoechea, E; Montilla, C; Salazar, JRGD; Garcia-Villanueva, MJ; Cano-Alameda, R; de Miera, FJTS; Novoa-Medina, FJ; Moriano-Morales, C; Bonilla, G; Narvaez, FJ; Andreu, JL; Arevalo-Salaet, M; Horcada, L; Cobo, T; Lozano-Rivas, N; Bohorquez, C; Iniguez-Ubiaga, CL; Salgado-Perez, E; Torrente-Segarra, V; Monte, TCS; Oller, JE; Pego-Reigosa, JM.

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 74: [doi:10.1016/j.semarthrit.2025.152819]

Ingegnoli, F; Ughi, N; Riccieri, V; Stefanantoni, K; Cracowski, JL; Gutierrez, M; Sulli, A; Rodriguez-Reyna, TS; Hame, A; Makol, A; Nuño-Nuño, L; Nieto-Gonzalez, JC; Kubo, S; Michalska-Jakubus, M; Pernaute, OS; De Angelis, R; Herrick, AL; Melsens, K; Cutolo, M; Smith, V.

Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseases

Rmd Open. 2025; 11(3): [doi:10.1136/rmdopen-2025-005772]

Rusinovich-Lovgach, O; Plaza, Z; Fernandez-Castro, M; de Salazar, JRG; Martinez-Taboada, VM; Olive, A; Menor-Almagro, R; Serrano-Benavente, B; Font-Urgelles, J; Garcia-Aparicio, A; Manrique-Arija, S; Garcia-Vadillo, JA; Lopez-Gonzalez, R; Narvaez-García, J; Rodriguez-Lozano, B; Galisteo, C; Gonzalez-Martin, JJ; Vela-Casasempere, P; Rabadán, E; Naranjo, A; Paredes-Romero, B; Riancho-Zarrabeitia, L; Melchor-Diaz, S; Altabás, I; Heredia, S; Moriano, C; Blazquez-Cañamero, A; Estrada-Alarcón, P; Judez, E; Alcorta-Lorenzo, N; Martínez-Pérez, R; Sánchez-Alonso, F; Andréu, JL.

High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort study

RHEUMATOLOGY INTERNATIONAL. 2025; 45(8): [doi:10.1007/s00296-025-05935-y]

Rusinovich-Lovgach O; Plaza Z; Castro MF; de Salazar JR; Martínez Taboada VM; Olive A; Almagro RM; Benavente BS; Urgelles JF; Garcia-Aparicio A; Manrique-Arija S; Vadillo JAG; Lopez-Gonzalez R; García JN; Lozano MBR; Galisteo C; Martin JJG; Casasempere PV; Rabadán E; Naranjo A; Romero MBP; Riancho-Zarrabeitia L; Diaz SM; Altabás I; Heredia S; Moriano C; Cañamero MAB; Estrada-Alarcón P; Judez E; Lorenzo NA; Loricera J; Pérez RM; Alonso FS; Sánchez JLA.

Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact.

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 73: 152743-152743 [doi:10.1016/j.semarthrit.2025.152743]

Rodriguez-Merlos, P; Cabrera-Alarcón, JL; Ruiz-Esquide, V; Chacur, CA; Sanmartí, R; De Miguel-Mendieta, E; Alvaro-Gracia, JM; Balsa, A; Plasencia-Rodríguez, C; Novella-Navarro, M.

Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold

ARTHRITIS RESEARCH & THERAPY. 2025; 27(1): [doi:10.1186/s13075-025-03621-9]